TSH Biopharm Corporation Limited

TPEX:8432 Stok Raporu

Piyasa değeri: NT$2.5b

TSH Biopharm Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

TSH Biopharm has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.7B and NT$224.2M respectively. TSH Biopharm's EBIT is NT$118.3M making its interest coverage ratio -10.5. It has cash and short-term investments of NT$684.2M.

Anahtar bilgiler

0%

Borç/özkaynak oranı

NT$0

Borç

Faiz karşılama oranı-10.5x
NakitNT$684.18m
EşitlikNT$1.51b
Toplam yükümlülüklerNT$224.20m
Toplam varlıklarNT$1.74b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 8432's short term assets (NT$1.2B) exceed its short term liabilities (NT$222.3M).

Uzun Vadeli Yükümlülükler: 8432's short term assets (NT$1.2B) exceed its long term liabilities (NT$1.9M).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 8432 is debt free.

Borcun Azaltılması: 8432 had no debt 5 years ago.

Borç Kapsamı: 8432 has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: 8432 has no debt, therefore coverage of interest payments is not a concern.

Bilanço

Sağlıklı şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y